Kongho Cho
Sungkyunkwan University · Medicine
About the Lab
Professor Kongho Cho's research lab specializes in thoracic surgery and oncology, with a primary focus on surgical management and prognostic evaluation of patients with advanced lung and colorectal cancers. The lab investigates outcomes following pulmonary metastasectomy, particularly the impact of metastatic burden, liver involvement, and biomarker expression (e.g., PD-L1, EGFR mutations) on survival and recurrence. It also explores minimally invasive techniques such as video-assisted thoracic surgery (VATS) for both diagnostic and therapeutic purposes, especially in challenging populations like those with interstitial lung disease or large tumors. The lab emphasizes individualized treatment strategies through precise prognostic modeling and oncological validity assessment.
Research Overview
Research Output Trend
Figures are computed from collected data and may differ slightly.
Selected Papers
15BACKGROUND: The presence of multiple metastatic pulmonary nodules is a predictor of poor survival after pulmonary metastasectomy. However, there is a paucity of data addressing the exact number of pulmonary metastases over which prognosis becomes grave. The aim of our study is to investigate the prognosis of pulmonary metastasectomy from colorectal cancer (CRC) depending on the number of pulmonary metastases. METHODS: Patients who had undergone pulmonary metastasectomy for CRC between November 1
BACKGROUND: Patients with malignant pleural effusion have a limited life expectancy. An increase in pleural and oncological treatment options and more accurate prognostic evaluation may help individualize treatment strategies. The aim of this study was to identify the prognostic indicators of overall survival (OS) after video-assisted thoracic surgery (VATS) talc pleurodesis for malignant pleural effusion. METHODS: We examined the medical records of all consecutive patients with malignant pleura
PD-L1 expression is associated with disease stage and type of <i>EGFR</i> mutation. PD-L1 positivity might be associated with worse RFS among patients with surgically treated <i>EGFR</i>-mutant NSCLC.
These preliminary results suggest that non-intubated VATS lung biopsy is a safe and feasible option in patients with ILD.
BACKGROUND: Our objective was to evaluate the influence of liver metastasis on survival after pulmonary metastasectomy in patients with colorectal cancer (CRC). METHODS: We retrospectively reviewed a total of 524 patients and were classified into two groups based on the presence of liver metastasis. Group HM + PM (n = 106) included patients who previously received a hepatic metastasectomy and then received pulmonary metastasectomy. Group PM (n = 418) included patients who only received pulmonary
BACKGROUND: There are several concerns on thoracoscopic surgery for large tumors because of the increased risk of tumor cell spillage. This study aimed to compare perioperative outcomes and oncological validity between video-assisted thoracoscopic surgery (VATS) and open lobectomy for non-small cell lung cancer (NSCLC) with tumor size > 5 cm. METHODS: We retrospectively reviewed 355 patients who underwent lobectomy with clinical N0 NSCLC with solid tumor component diameter > 5 cm between January
OBJECTIVE: To analyze conditional survival estimates of patients with esophageal cancer who underwent curative resection. SUMMARY BACKGROUND DATA: Conditional survival reflects dynamic prognosis updated to the current status and is a more relevant indicator for current healthcare and life decisions. METHODS: This study included 1883 patients who underwent complete resection for esophageal squamous cell carcinoma at a tertiary cancer center from 1994 to 2016. We calculated 5-year (5Y) conditional
Research Areas
Dive deeper into Kongho Cho's research on Nubint
Open this lab's papers in the app to read with AI, summarize, and cite in your writing.